British Journal of Pharmacology · 2000 · 25 citations · 37 references
MedicineNeurosciencePharmacologyNeurochemistryNeuropharmacologyPharmacodynamicsBiomarkers Of NeurotoxicityImmunosuppressionImmunosuppressive AgentsNeurochemical PharmacologyNeuroprotectionBrain Drug MetabolismCellular Phosphate MetabolismCyclosporine InteractionsImmunosuppressive Drug ToxicityNeurotoxicity Of Immunosuppressive TherapyRegional Brain MetabolismTriose Phosphate Metabolism
1. SDZ-RAD, 40-O-(2-hydroxyethyl)-rapamycin, is a novel macrolide immunosuppressant. Because of its synergistic interaction, SDZ-RAD is under clinical investigation as immunosuppressant in combination with cyclosporine after organ transplantation. Neurotoxicity is a critical side-effect of cyclosporine. 2. We studied the effect of SDZ-RAD and its combination with cyclosporine on high-energy phosphates, phosphocreatine (PCr) and nucleoside triphosphates (NTP), in brain slices using 31P-magnetic resonance spectroscopy (MRS). 3. Cyclosporine significantly reduced high-energy phosphates after 2 h in a dose-dependent manner (100 micrograms l-1: 93 +/- 3% of control (NTP), 91 +/- 3% (PCr); 500 micrograms l-1: 84 +/- 2% (NTP), 73 +/- 2 (PCr); 5000 micrograms l-1: 68 +/- 3% (NTP), 55 +/- 5% (PCr); n = 6; P < 0.02). 4. In contrast, after perfusion for 2 h, SDZ-RAD (500 micrograms l-1 and 5000 micrograms l-1) significantly increased high-energy phosphate concentrations in the brain slices (P < 0.02). Even at the lowest concentration, SDZ-RAD protected brain energy metabolism against cyclosporine toxicity: 100 micrograms l-1 SDZ-RAD + 5000 micrograms l-1 cyclosporine: 86 +/- 3% (NTP), 83 +/- 7% (PCr), n = 3, P < 0.03 compared to cyclosporine alone. 5. As evaluated using an algorithm based on Loewe isobolograms, the effects of SDZ-RAD/cyclosporine combinations on brain energy reduction were antagonistic. Both drugs were found in mitochondria using h.p.l.c-MS analysis. 6. We conclude that cyclosporine inhibits mitochondrial high-energy phosphate metabolism, which can be antagonized by SDZ-RAD.
37
Thomas Kronbach, Volker Fischer, Urs Meyer · Clinical Pharmacology & Therapeutics · 1988 · 539 citations
Medicine, Biochemistry, Pharmacology +17
SDZ RAD, A NEW RAPAMYCIN DERIVATIVE
W. Schüler, Richard Sedrani, Sylvain Cottens et al. · Transplantation · 1997 · 538 citations
Central Nervous System Toxicity after Liver Transplantation
Piet C. de Groen, Allen J. Aksamit, Jorge Rakela et al. · New England Journal of Medicine · 1987 · 508 citations
Medicine, Neurology, Pharmacology +17
Cardiac defects and altered ryanodine receptor function in mice lacking FKBP12
Weinian Shou, Bahman Aghdasi, Dawna L. Armstrong et al. · Nature · 1998 · 424 citations · Full text